Bausch, B. et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr. Relat. Cancer 21, 17–25 (2014).
Ciftci, A. O., Tanyel, F. C., Şenocak, M. E. & Büyükpamukçu, N. Pheochromocytoma in children. J. Pediatr. Surg. 36, 447–452 (2001).
Article CAS PubMed Google Scholar
Hume, D. M. Pheochromocytoma in the adult and in the child. Am. J. Surg. 99, 458–496 (1960).
Article CAS PubMed Google Scholar
Wyszyńska, T., Cichocka, E., Wieteska‐Klimczak, A., Jobs, K. & Januszewicz, P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. 81, 244–246 (1992).
Barontini, M., Levin, G. & Sanso, G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann. N. Y. Acad. Sci. 1073, 30–37 (2006).
Pamporaki, C. et al. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 102, 1122–1132 (2017).
Article PubMed PubMed Central Google Scholar
Neumann, H. P. H. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346, 1459–1466 (2002).
Article CAS PubMed Google Scholar
de Tersant, M. et al. Pheochromocytoma and paraganglioma in children and adolescents: experience of the French Society of Pediatric Oncology (SFCE). J. Endocr. Soc. 4, bvaa039 (2020).
Article PubMed PubMed Central Google Scholar
Redlich, A. et al. Pseudohypoxic pheochromocytomas and paragangliomas dominate in children. Pediatr. Blood Cancer 68, e28981 (2021).
Article CAS PubMed Google Scholar
Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181–193 (2017).
Article CAS PubMed PubMed Central Google Scholar
Dahia, P. L. M. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat. Rev. Cancer 14, 108–119 (2014).
Article CAS PubMed Google Scholar
Michałowska, I. et al. Growth rate of paragangliomas related to germline mutations of the SDHx genes. Endocr. Pract. 23, 342–352 (2017).
Pham, T. H. et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118, 1109–1117 (2006).
Davidoff, D. F. et al. Surveillance improves outcomes for carriers of SDHB pathogenic variants: a multicenter study. J. Clin. Endocrinol. Metab. 107, e1907–e1916 (2022).
Article PubMed PubMed Central Google Scholar
Amar, L. et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat. Rev. Endocrinol. 17, 435–444 (2021).
Article CAS PubMed PubMed Central Google Scholar
Atkins, D. et al. Grading quality of evidence and strength of recommendations. BMJ 328, 1490 (2004).
Swiglo, B. A. et al. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J. Clin. Endocrinol. Metab. 93, 666–673 (2008).
Article CAS PubMed Google Scholar
Fassnacht, M. et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1476–1490 (2020).
Article CAS PubMed Google Scholar
PDQ Pediatric Treatment Editorial Board. Childhood pheochromocytoma and paraganglioma treatment (PDQ®): health professional version. In PDQ Cancer Information Summaries (National Cancer Institute, 2022).
Lenders, J. W. M. et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 1915–1942 (2014).
Article CAS PubMed Google Scholar
Croke, J. M. & El-Sayed, S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr. Oncol. 19, 232–238 (2012).
Magi, L. et al. Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center. J. Clin. Med. 8, 910 (2019).
Article PubMed PubMed Central Google Scholar
Metz, D. C. et al. A rationale for multidisciplinary care in treating neuroendocrine tumours. Curr. Opin. Endocrinol. Diabetes Obes. 19, 306–313 (2012).
Taïeb, D. et al. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 11, 345–361 (2023).
Article PubMed PubMed Central Google Scholar
Révillon, Y. et al. Pheochromocytoma in children: 15 cases. J. Pediatr. Surg. 27, 910–911 (1992).
Virgone, C. et al. Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP). Pediatr. Blood Cancer 67, e28332 (2020).
Article CAS PubMed Google Scholar
Geroula, A. et al. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. Eur. J. Endocrinol. 181, 409–420 (2019).
Article CAS PubMed Google Scholar
King, K. S., Darmani, N. A., Hughes, M. S., Adams, K. T. & Pacak, K. Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma. Endocrine 37, 403–407 (2010).
Article CAS PubMed PubMed Central Google Scholar
Batsis, M. et al. Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma. Horm. Metab. Res. 48, 509–513 (2016).
Article CAS PubMed PubMed Central Google Scholar
Sullivan, J., Groshong, T. & Tobias, J. D. Presenting signs and symptoms of pheochromocytoma in pediatric-aged patients. Clin. Pediatr. 44, 715–719 (2005).
Flynn, J. T. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140, e20171904 (2017).
Chandar, J. & Zilleruelo, G. Hypertensive crisis in children. Pediatr. Nephrol. 27, 741–751 (2012).
Lenders, J. W., Eisenhofer, G., Mannelli, M. & Pacak, K. Phaeochromocytoma. Lancet 366, 665–675 (2005).
Reddy, V. S. et al. Twenty-five-year surgical experience with pheochromocytoma in children. Am. Surg. 66, 1085–1091 (2000).
Comments (0)